Zou Ning, Ao Lihua, Cleveland Joseph C, Yang Xiaoping, Su Xin, Cai Guang-Yun, Banerjee Anirban, Fullerton David A, Meng Xianzhong
Department of Surgery, University of Colorado Denver, Denver, Colorado, USA.
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2805-13. doi: 10.1152/ajpheart.00299.2008. Epub 2008 Apr 25.
Previous studies showed that Toll-like receptor 4 (TLR4) modulates the myocardial inflammatory response to ischemia-reperfusion injury, and we recently found that cytokines link TLR4 to postischemic cardiac dysfunction. Although TLR4 can be activated in cultured cells by endogenous agents including heat shock protein 70, how it is activated during myocardial ischemia-reperfusion is unknown. In the present study, we examined 1) whether heat shock cognate protein 70 (HSC70), which is constitutively expressed in the myocardium, is released during ischemia-reperfusion; 2) whether extracellular HSC70 induces the myocardial inflammatory response and modulates cardiac function; and 3) whether HSC70 exerts these effects via TLR4. We subjected isolated mouse hearts to global ischemia-reperfusion via the Langendorff technique. Immunoblotting and immunostaining detected the release of HSC70 from the myocardium during reperfusion. Treatment with an antibody specific to HSC70 suppressed myocardial cytokine expression and improved cardiac functional recovery after ischemia-reperfusion. Recombinant HSC70 induced NF-kappaB activation and cytokine expression and depressed myocardial contractility in a TLR4-dependent manner. These effects required the substrate-binding domain of HSC70. Fluorescence resonance energy transfer analysis of isolated macrophages demonstrated that extracellular HSC70 interacts with TLR4. Therefore, this study demonstrates for the first time that 1) the myocardium releases HSC70 during ischemia-reperfusion, 2) extracellular HSC70 contributes to the postischemic myocardial inflammatory response and to cardiac dysfunction, 3) HSC70 exerts these effects through a TLR4-dependent mechanism, and 4) the substrate-binding domain of HSC70 is required to induce these effects. Thus extracellular HSC70 plays a critical role in regulating the myocardial innate immune response and cardiac function after ischemia-reperfusion.
以往研究表明,Toll样受体4(TLR4)可调节心肌对缺血再灌注损伤的炎症反应,并且我们最近发现细胞因子将TLR4与缺血后心脏功能障碍联系起来。尽管TLR4可在培养细胞中被包括热休克蛋白70在内的内源性因子激活,但在心肌缺血再灌注期间它是如何被激活的尚不清楚。在本研究中,我们检测了:1)心肌中组成性表达的热休克同源蛋白70(HSC70)在缺血再灌注期间是否释放;2)细胞外HSC70是否诱导心肌炎症反应并调节心脏功能;3)HSC70是否通过TLR4发挥这些作用。我们通过Langendorff技术对离体小鼠心脏进行全心缺血再灌注。免疫印迹和免疫染色检测到再灌注期间心肌中HSC70的释放。用HSC70特异性抗体处理可抑制心肌细胞因子表达,并改善缺血再灌注后的心脏功能恢复。重组HSC70以TLR4依赖的方式诱导核因子κB激活和细胞因子表达,并降低心肌收缩力。这些效应需要HSC70的底物结合结构域。对分离的巨噬细胞进行的荧光共振能量转移分析表明,细胞外HSC70与TLR4相互作用。因此,本研究首次证明:1)心肌在缺血再灌注期间释放HSC70;2)细胞外HSC70促成缺血后心肌炎症反应和心脏功能障碍;3)HSC70通过TLR4依赖机制发挥这些作用;4)HSC70的底物结合结构域是诱导这些效应所必需的。因此,细胞外HSC70在调节缺血再灌注后心肌固有免疫反应和心脏功能中起关键作用。